Provider Education: Lung Cancer Updates in Biomarker Testing and Treatment

Back to all Events
Events Calendar

Provider Education: Lung Cancer Updates in Biomarker Testing and Treatment

Join us for a Provider Education Program in Winston Salem.

Provider Education: Lung Cancer Updates in Biomarker Testing and Treatment

With treatment options for lung cancer expanding rapidly, the role of comprehensive biomarker testing in lung cancer treatment remains integral. Testing is needed to guide the provider through precision medicine options which are unique to each patient’s lung cancer. This event aims to educate on the latest developments in comprehensive biomarker testing and targeted therapies for lung cancer.

TARGET AUDIENCE
Medical oncologists and fellows, residents, physician assistants and nurse practitioners working with medical oncologists

LEARNING OBJECTIVES
At the conclusion of this educational activity, the participant should be able to:

  • Examine the role of biomarkers and testing strategies in optimizing and personalizing treatment selection in patients with thoracic malignancies.
  • Integrate molecular testing into treatment planning for patients and appropriately identify patients who would benefit from new agents.

SPEAKERS

  • Lynne S. Rosenblum, PhD, FACMG
  • Christopher Giauque, PhD
  • Thomas W. Lycan JR., DO, MHS

AGENDA

  • 6:00 – Registration, dinner and visit with exhibitors
  • 6:45 – Current and Future Lung Cancer testing at Wake Forest: It’s All in the Genes
  • 7:15 – Advancements in lung cancer targeted treatment options
  • 7:45 – Question & Answer
  • 8:00 – Closing/visit with exhibitors

REGISTRATION

  • $30 for healthcare providers
  • Register online by May 19, 2025 | Seating is limited to the first 30 registrants
  • Dinner & drinks are provided
Venue
info